UPC_APP_32529/2025

BIOTELEMETRY DEVICE THAT CAN BE INGESTED AND IMPLANTED IN VIVO

BerufungenEPA / EntscheidungsberufungMilan CDAction against the decision of the EPO (RoP97)—

Übersicht Entscheidungen Zitate Dokumente Zeitverlauf

Parteien

Kläger

Bodycap
Centre National de la Recherche Scientifique (CNRS)
Université de Rennes

Vertreter: Geoffroy Cousin (Novagraaf)

Beklagte

EPO (Office européen des brevets)

Richter

Andrea PostiglioneDuty judge

Patente

EP 3 691 518

CPC-Codes: A61B5/0031, A61B5/0537, A61B5/0507, A61B5/073, A61B1/041, A61B5/07, A61B5/7225, A61B5/0538

Sektor: Pharmaceutical & Medical

Ausgang

Abgewiesen

Eingereicht: —

Erste Entscheidung: 6. Aug. 2025

Sprache: —

Order of Central Division Milan Section (duty judge, in French) dismissing Bodycap, CNRS and Université de Rennes' appeal (under R. 97 RoP) against the EPO's rejection of their unitary effect request for EP 3 691 518. The EPO had correctly applied R. 6.2 and R. 7.3 of the Implementing Regulations for Unitary Protection (RPU): after the university reorganisation (Université de Rennes I dissolved and replaced by Université de Rennes), the new address had not been provided in the unitary effect application within the one-month non-extendable deadline under R. 7.3 RPU. Each party bears its own costs.